comparemela.com

Latest Breaking News On - Johnl marshall - Page 6 : comparemela.com

Opportunities for Innovation in GI Cancer Treatment Landscape

In his closing thoughts, Dr Marshall shares final takeaways from the 2023 ASCO GI Cancers Symposium.

Johnl-marshall
Dmcrc
Gi-cancer
Liver-directed-therapies
Neoadjuvant-therapy
Msi-high
Non-operative

ASCO GI 2023: SPOTLIGHT Study

The SPOTLIGHT study results presented at the 2023 ASCO GI Cancers Symposium are explored by Dr Marshall.

Johnl-marshall
Gi-cancer
Junction-protein
Zolbetuximab
Claudin-18
Monoclonal-antibody
Her2-overexpression
Progression-free-survival
Overall-survival
Ngs-testing
Immunohistochemistry-tests

Utilizing RWE to Address Unmet Needs for CRC

Dr Marshall shares insights directed at the use of real-world evidence [RWE] and its impact on unmet needs in colorectal cancer [CRC] treatment.

Johnl-marshall
Colorectal-cancer
Dmcrc
Adjuvant-chemotherapy

Real-World Evidence (RWE) Supporting Use of ctDNA

A medical expert discusses real-world analyses surrounding the use of ctDNA.

Japan
Johnl-marshall
Siemens
Gi-cancer
Ctdna
Tumor
Dna
Guardant
Inform-database
Guardant360
Minimal-residual-disease

Drs. Roger B. Cohen, Lee M. Ellis and John L. Marshall Join Actuate Therapeutics' Scientific Advisory Board

Drs. Roger B. Cohen, Lee M. Ellis and John L. Marshall Join Actuate Therapeutics’ Scientific Advisory Board - read this article along with other careers information, tips and advice on BioSpace

United-states
United-kingdom
Texas
Chicago
Illinois
American
John-marshall
Daniel-billadeau
Lee-ellis
Patricia-lorusso
Daniel-schmitt
Leem-ellis

vimarsana © 2020. All Rights Reserved.